Targeting canine mammary tumours via gold nanoparticles functionalized with promising Co(II) and Zn(II) compounds

Detalhes bibliográficos
Autor(a) principal: Raposo, L. R.
Data de Publicação: 2017
Outros Autores: Roma-Rodrigues, C., Jesus, J., Martins, Luisa, Pombeiro, Armando, Baptista, P. V., Fernandes, A. R.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.21/7645
Resumo: Background: Despite continuous efforts, the treatment of canine cancer has still to deliver effective strategies. For example, traditional chemotherapy with doxorubicin and/or docetaxel does not significantly increase survival in dogs with canine mammary tumors (CMTs). Aims: Evaluate the efficiency of two metal compounds [Zn(DION)2]Cl (TS262, DION = 1,10- phenanthroline-5,6-dione) and [CoCl(H2O)(DION)2][BF4] (TS265) and novel nanovectorizations designed to improve the anti-cancer efficacy of these compounds in a new CMT derived cell line (FR37-CMT). Materials and methods: FR37-CMT cells were exposed to different concentrations of TS262 and TS265 and two new nanoparticle systems and cellular viability was determined. These nanosystems are composed of polyethylene-glycol, bovine-serum-albumin and TS262 or TS265 (NanoTS262 or NanoTS265, respectively). Results: In FR37-CMT, TS262 and TS265 displayed IC50 values well below those displayed by doxorubicin and cisplatin. The nanovectorizations further decreased the IC50 values. Discussion: TS262 and TS265 proved to be effective against FR37-CMT cells and more effective than of doxorubicin and cisplatin. The Nanosystems efficiently delivered the cytotoxic cargo inducing a significant reduction of cell viability in FR37-CMT cell line when compared to the free compounds. Conclusions: TS262 and TS265 are compounds with potential in the treatment of CMTs. NanoTS262 and NanoTS265 demonstrate that such simple nanovectorization via gold nanoparticles shows tremendous potential as anti-cancer formulations, which may easily be expanded to suit other cargo.
id RCAP_beb3404675f51069b6a373862c29e2d6
oai_identifier_str oai:repositorio.ipl.pt:10400.21/7645
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Targeting canine mammary tumours via gold nanoparticles functionalized with promising Co(II) and Zn(II) compoundscanine mammary tumourscisplatindoxorubicinFR37-CMTgold nanoparticlesnanotechnologyBackground: Despite continuous efforts, the treatment of canine cancer has still to deliver effective strategies. For example, traditional chemotherapy with doxorubicin and/or docetaxel does not significantly increase survival in dogs with canine mammary tumors (CMTs). Aims: Evaluate the efficiency of two metal compounds [Zn(DION)2]Cl (TS262, DION = 1,10- phenanthroline-5,6-dione) and [CoCl(H2O)(DION)2][BF4] (TS265) and novel nanovectorizations designed to improve the anti-cancer efficacy of these compounds in a new CMT derived cell line (FR37-CMT). Materials and methods: FR37-CMT cells were exposed to different concentrations of TS262 and TS265 and two new nanoparticle systems and cellular viability was determined. These nanosystems are composed of polyethylene-glycol, bovine-serum-albumin and TS262 or TS265 (NanoTS262 or NanoTS265, respectively). Results: In FR37-CMT, TS262 and TS265 displayed IC50 values well below those displayed by doxorubicin and cisplatin. The nanovectorizations further decreased the IC50 values. Discussion: TS262 and TS265 proved to be effective against FR37-CMT cells and more effective than of doxorubicin and cisplatin. The Nanosystems efficiently delivered the cytotoxic cargo inducing a significant reduction of cell viability in FR37-CMT cell line when compared to the free compounds. Conclusions: TS262 and TS265 are compounds with potential in the treatment of CMTs. NanoTS262 and NanoTS265 demonstrate that such simple nanovectorization via gold nanoparticles shows tremendous potential as anti-cancer formulations, which may easily be expanded to suit other cargo.WileyRCIPLRaposo, L. R.Roma-Rodrigues, C.Jesus, J.Martins, LuisaPombeiro, ArmandoBaptista, P. V.Fernandes, A. R.2017-12-05T10:22:57Z2017-122017-12-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.21/7645engRAPOSO, L. R.; [et al] – Targeting canine mammary tumours via gold nanoparticles functionalized with promising Co(II) and Zn(II) compounds. Veterinary and Comparative Oncology. ISSN 1476-5810. Vol. 15, N.º 4 (2017), pp. 1537-15421476-581010.1111/vco.12298metadata only accessinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-08-03T09:53:58Zoai:repositorio.ipl.pt:10400.21/7645Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T20:16:32.440595Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Targeting canine mammary tumours via gold nanoparticles functionalized with promising Co(II) and Zn(II) compounds
title Targeting canine mammary tumours via gold nanoparticles functionalized with promising Co(II) and Zn(II) compounds
spellingShingle Targeting canine mammary tumours via gold nanoparticles functionalized with promising Co(II) and Zn(II) compounds
Raposo, L. R.
canine mammary tumours
cisplatin
doxorubicin
FR37-CMT
gold nanoparticles
nanotechnology
title_short Targeting canine mammary tumours via gold nanoparticles functionalized with promising Co(II) and Zn(II) compounds
title_full Targeting canine mammary tumours via gold nanoparticles functionalized with promising Co(II) and Zn(II) compounds
title_fullStr Targeting canine mammary tumours via gold nanoparticles functionalized with promising Co(II) and Zn(II) compounds
title_full_unstemmed Targeting canine mammary tumours via gold nanoparticles functionalized with promising Co(II) and Zn(II) compounds
title_sort Targeting canine mammary tumours via gold nanoparticles functionalized with promising Co(II) and Zn(II) compounds
author Raposo, L. R.
author_facet Raposo, L. R.
Roma-Rodrigues, C.
Jesus, J.
Martins, Luisa
Pombeiro, Armando
Baptista, P. V.
Fernandes, A. R.
author_role author
author2 Roma-Rodrigues, C.
Jesus, J.
Martins, Luisa
Pombeiro, Armando
Baptista, P. V.
Fernandes, A. R.
author2_role author
author
author
author
author
author
dc.contributor.none.fl_str_mv RCIPL
dc.contributor.author.fl_str_mv Raposo, L. R.
Roma-Rodrigues, C.
Jesus, J.
Martins, Luisa
Pombeiro, Armando
Baptista, P. V.
Fernandes, A. R.
dc.subject.por.fl_str_mv canine mammary tumours
cisplatin
doxorubicin
FR37-CMT
gold nanoparticles
nanotechnology
topic canine mammary tumours
cisplatin
doxorubicin
FR37-CMT
gold nanoparticles
nanotechnology
description Background: Despite continuous efforts, the treatment of canine cancer has still to deliver effective strategies. For example, traditional chemotherapy with doxorubicin and/or docetaxel does not significantly increase survival in dogs with canine mammary tumors (CMTs). Aims: Evaluate the efficiency of two metal compounds [Zn(DION)2]Cl (TS262, DION = 1,10- phenanthroline-5,6-dione) and [CoCl(H2O)(DION)2][BF4] (TS265) and novel nanovectorizations designed to improve the anti-cancer efficacy of these compounds in a new CMT derived cell line (FR37-CMT). Materials and methods: FR37-CMT cells were exposed to different concentrations of TS262 and TS265 and two new nanoparticle systems and cellular viability was determined. These nanosystems are composed of polyethylene-glycol, bovine-serum-albumin and TS262 or TS265 (NanoTS262 or NanoTS265, respectively). Results: In FR37-CMT, TS262 and TS265 displayed IC50 values well below those displayed by doxorubicin and cisplatin. The nanovectorizations further decreased the IC50 values. Discussion: TS262 and TS265 proved to be effective against FR37-CMT cells and more effective than of doxorubicin and cisplatin. The Nanosystems efficiently delivered the cytotoxic cargo inducing a significant reduction of cell viability in FR37-CMT cell line when compared to the free compounds. Conclusions: TS262 and TS265 are compounds with potential in the treatment of CMTs. NanoTS262 and NanoTS265 demonstrate that such simple nanovectorization via gold nanoparticles shows tremendous potential as anti-cancer formulations, which may easily be expanded to suit other cargo.
publishDate 2017
dc.date.none.fl_str_mv 2017-12-05T10:22:57Z
2017-12
2017-12-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.21/7645
url http://hdl.handle.net/10400.21/7645
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv RAPOSO, L. R.; [et al] – Targeting canine mammary tumours via gold nanoparticles functionalized with promising Co(II) and Zn(II) compounds. Veterinary and Comparative Oncology. ISSN 1476-5810. Vol. 15, N.º 4 (2017), pp. 1537-1542
1476-5810
10.1111/vco.12298
dc.rights.driver.fl_str_mv metadata only access
info:eu-repo/semantics/openAccess
rights_invalid_str_mv metadata only access
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Wiley
publisher.none.fl_str_mv Wiley
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1817551197717921792